Yehonatan Sharabi

3PUBLICATIONS
7CO-AUTHORS
Molecular medicineToxicology (incl. clinical toxicology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 12, 2023
Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease.

Rawan Khashab, Naama Gutman-Sharabi, Zehava Shabtai

|Nov 29, 2021
The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease.

Regev Landau, Reut Halperin, Patti Sullivan

|Jul 21, 2021
Parkinson Disease-Modification Encompassing Rotenone and 6-Hydroxydopamine Neurotoxicity by the Microtubule-Protecting Drug Candidate SKIP.

Yanina Ivashko-Pachima, Kim B Seroogy, Yehonatan Sharabi

Pageof 1

Frequent Collaborators

2 joint publications

Regev Landau

1 joint publications

Yanina Ivashko-Pachima

1 joint publications

Kim B Seroogy

1 joint publications

Illana Gozes